Filtered By:
Management: Insurance
Vaccination: Shingles (Herpes Zoster) Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 127 results found since Jan 2013.
Herpes zoster reactivation after mRNA and adenovirus-vectored coronavirus disease 2019 vaccination: Analysis of National Health Insurance Database
CONCLUSIONS: mRNA COVID-19 vaccination possibly increases the risk of herpes zoster reactivation, and thus close follow-up for herpes zoster reactivation is required.PMID:37549237 | DOI:10.1093/infdis/jiad297
Source: Herpes - August 7, 2023 Category: Infectious Diseases Authors: Jin Gu Yoon Young-Eun Kim Min Joo Choi Won Suk Choi Yu Bin Seo Jaehun Jung Hak-Jun Hyun Hye Seong Eliel Nham Ji Yun Noh Joon Young Song Woo Joo Kim Dong Wook Kim Hee Jin Cheong Source Type: research
Multiregional Population-Based Cohort Study for Evaluation of the Association Between Herpes Zoster and mRNA Vaccinations for Severe Acute Respiratory Syndrome Coronavirus-2: The VENUS Study
CONCLUSIONS: No increased risk of HZ was found after BNT162b2 vaccination in the overall study population. However, an increased risk was observed in the younger subgroup.PMID:37404955 | PMC:PMC10316690 | DOI:10.1093/ofid/ofad274
Source: Herpes - July 5, 2023 Category: Infectious Diseases Authors: Chieko Ishiguro Wataru Mimura Yukari Uemura Megumi Maeda Fumiko Murata Haruhisa Fukuda Source Type: research
A study on knowledge, attitude, and vaccination behavior of herpes zoster vaccine among urban residents in selected areas of China
Conclusion: Low knowledge of herpes zoster and its vaccine, positive attitudes towards the preventive effects of herpes zoster and its vaccine, and extremely low vaccination rates among the urban population in China call for multiple measures to strengthen health education and vaccination recommendations for residents, especially for the elderly, low-education and low-income populations.PMID:37380410 | DOI:10.3760/cma.j.cn112338-20221125-00998
Source: Herpes - June 28, 2023 Category: Infectious Diseases Authors: M Wang C Long M Z Hu Y S Wang Y Q Xia B B Yuan D W Zhu P He Source Type: research
Associations between income changes and the risk of herpes zoster: LIFE study
Soc Sci Med. 2023 May 22;328:115981. doi: 10.1016/j.socscimed.2023.115981. Online ahead of print.ABSTRACTEconomic stability is thought to be associated with health outcomes. Income changes may affect the occurrence of herpes zoster (HZ), which is a neurocutaneous disease caused by the varicella-zoster virus. This retrospective cohort study aimed to examine the associations between annual income changes and incident HZ in a Japanese population. The analysis was conducted using a database of public health insurance claims data linked with administrative data containing income levels. The study population comprised 48,317 mid...
Source: Herpes - June 3, 2023 Category: Infectious Diseases Authors: Hiroaki Onizuka Haruhisa Fukuda Source Type: research
Factors influencing herpes zoster vaccination among older people in China: results from a discrete choice experiment
CONCLUSIONS: Improving medical insurance coverage or reducing the cost of the HZ vaccine will encourage more people to be vaccinated, resulting in reduced burden of disease among older people.PMID:37263175 | DOI:10.1016/j.puhe.2023.04.025
Source: Herpes - June 1, 2023 Category: Infectious Diseases Authors: H Zhang L R Zhang L C Chu X Sun X W Jiang Source Type: research
Liver Cirrhosis Increases the Risk of Herpes Zoster: A Nationwide Population-based Cohort Study
CONCLUSION: Patients with LC, particularly those who are not currently recommended for HZ vaccination, were at an increased risk of HZ and HZ-related hospitalization compared to the general Korean population.PMID:36746415 | DOI:10.14309/ajg.0000000000002209
Source: Herpes - February 6, 2023 Category: Infectious Diseases Authors: Dongsub Jeon Ye-Jee Kim Seonok Kim Won-Mook Choi Danbi Lee Ju Hyun Shim Kang Mo Kim Young-Suk Lim Han Chu Lee Jonggi Choi Source Type: research
Patterns of use of recombinant zoster vaccine among commercially-insured immunocompetent and immunocompromised adults 50-64 years old in the United States
CONCLUSIONS: RZV uptake was low in the two years since the CDC recommendation, and differed by demographic, healthcare access, and clinical characteristics. Initiation rates were higher among immunocompromised adults compared to immunocompetent adults, despite no CDC recommendation for vaccination in these groups during the study period. The CDC has since recommended RZV for immunocompromised individuals, and our findings may inform efforts to increase RZV uptake in individuals at higher risk of severe disease.PMID:36396511 | DOI:10.1016/j.vaccine.2022.10.076
Source: Herpes - November 17, 2022 Category: Infectious Diseases Authors: Jonathan Fix Nadja A Vielot Jennifer L Lund David J Weber Jennifer S Smith Michael G Hudgens Sylvia Becker-Dreps Source Type: research
Chondromalacia patella increases the risk of herpes zoster: a population-based study
CONCLUSION: Patients with CMP, especially elder adults and women, exhibited a higher risk of HZ. The HZ risk of patients with CMP should thus be assessed, and the necessity of HZ vaccination should be informed.PMID:36348331 | DOI:10.1186/s12891-022-05929-y
Source: Herpes - November 8, 2022 Category: Infectious Diseases Authors: Chia-Hung Chen Yung-Chi Cheng Hsin-Yi Yang Ching-Fang Tsai Chao-Yu Hsu Der-Shin Ke Wen-Che Hsieh Source Type: research
Sequential Data-Mining for Adverse Events after Recombinant Herpes Zoster Vaccination Using the Tree-Based Scan Statistic
In this study, the binomial tree-based scan statistic was applied sequentially to detect adverse events in Days 1-28 compared with Days 29-56 after recombinant herpes zoster (RZV) vaccination, with 5 looks at the data and formal adjustment for the repeated analyses over time. IBM Marketscan data on commercially insured persons 50+ years of age receiving RZV during January 1, 2018-May 5, 2020 were used. With 999,876 doses of RZV included, statistically significant signals were detected only for unspecified adverse effects/complications following immunization, with attributable risks as low as 2 excess cases per 100,000 vacc...
Source: Am J Epidemiol - October 13, 2022 Category: Epidemiology Authors: W Katherine Yih Martin Kulldorff Inna Dashevsky Judith C Maro Source Type: research
